Abstract
IntroductionThe persistent development and spread of resistance to antibiotics remain an important public health concern in the UK and globally. About 74% of antibiotics prescribed in England in 2016 was...
Highlights
The persistent development and spread of resistance to antibiotics remain an important public health concern in the UK and globally
Study aim and objectives Using routinely collected population-level data on antibiotic prescribing in England, this study aims to address the research question: What are the mechanisms and mediators of the impact of a high-cost health-system level intervention, the ‘antibiotic prescribing quality premium’? We will investigate the difference in antibiotic prescribing rate pre-Quality Premium (QP) and post-QP initiative to establish its direct, indirect and total effects in reducing antibiotic prescribing in primary care practices in England
Clinical Commissioning Groups (CCGs) were established in England in April 2013 following the Health and Social Care Act 2012.33 Data on antibiotic prescribing in primary care at CCG level will be sourced from the National Health Service (NHS) England Antibiotic Quality Premium Monitoring Dashboard, which is produced by the NHS Business Services Authority (BSA).[34]
Summary
The persistent development and spread of resistance to antibiotics remain an important public health concern in the UK and globally. The Quality Premium (QP) initiative that rewards Clinical Commissioning Groups (CCGs) financially based on the quality of specific health services commissioned is one of the National Health Service (NHS) England interventions to reduce antimicrobial resistance through reduced prescribing. This study aims to investigate the mechanism of impact of this high-cost health-system level intervention on antibiotic prescribing in primary care practices in England. Methods and analysis The study will constitute secondary analyses of antibiotic prescribing data for almost all primary care practices in England from the NHS England Antibiotic Quality Premium Monitoring Dashboard and OpenPrescribing covering the period 2013 to 2018. The persistent development and spread of resistance to antimicrobials, especially antibiotics, remain an important public health
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
